INK4a gene is frequently inactivated in acute lymphoblastic leukemia (ALL), by homozygous deletion. However, p16 
Introduction

p15
INK4b and p16 INK4a proteins are cell cycle regulators involved in the inhibition of G1 phase progression. Both proteins associate with cyclin dependent kinase 4 and 6 (CDK4, CDK6), and cyclin D-CDK4/6 complexes and inhibit their kinase activities. p16
INK4a and p15 INK4b genes are homozygously deleted in many tumor types including acute lymphoblastic leukemia (ALL). 1 Correlations between p16 INK4a gene status and prognosis remain controversial, due in part to the small number of patients analyzed. It has been reported that patients with ALL homozygously deleted for the p16
INK4a gene had a greater leukemic mass and higher blood cell count, but these findings were not confirmed by other studies.
2 p16 INK4a protein expression has also been investigated with various results. Mekki et al 3 observed that enhanced expression of p16
INK4a protein was associated with poor prognosis in childhood ALL.
In the CALGB study survival and remission duration did not differ between patients with or without p16 INK4a inactivation. 4 Another report using p16 INK4a immunocytochemistry (ICC) failed to show statistical prognosis difference between ALL expressing and not expressing p16
INK4a protein. 5 However, a recent study has shown that when combined with other tumor suppressor gene expression analysis, p16
INK4a gene status might be an important determinant of disease outcome. 4 It has been proposed that p16 INK4a 
Materials and methods
Patients
We analyzed p16 INK4a gene expression by ICC in 76 adult ALL (51 early B ALL, 15 T ALL, five Burkitt's ALL, and five poorly differentiated). Sixty-two of those patients were newly diagnosed ALL and 19 were analyzed in first relapse. Patients were treated according to the GOELAL and LALA French regimen, except the five Burkitt's ALL treated according to the LMBA95 protocol. Eight patients were studied by ICC at diagnosis and in first relapse, three of them also in second relapse. We also studied the correlation between p16
INK4a gene status established by FISH and ICC results in 23 ALL (eight T-ALL, 11 B-ALL, four Burkitt's ALL). Eight bone marrow smears from non-ALL patients were analyzed as controls (one non-Hodgkin's lymphoma without bone marrow involvement, one infectionrelated thrombocytopenia, three AML in long-term complete remission, three immune thrombocytopenias).
Immunocytochemistry
Immunocytochemical detection of p16
INK4a protein was performed with 2 g/ml of the IgG1 kappa mouse MoAb antihuman p16 INK4a (clone DCS-50.1/H4, Oncogene Research Products, Cambridge, UK) as previously described. 8 Slides were fixed for 10 min in cold acetone and washed in buffered saline prior to labelling. The ICC reaction was performed with avidin-biotin-peroxidase (ABC) technique using Vector reagents (Vector Laboratories, Burlingame, CA, USA). Slides were incubated sequentially with peroxidase blocking reagent, containing H 2 O 2 and sodium azide (Dakopatts, Glostrup, Denmark) for 10 min to inhibit endogenous peroxidase activity, followed by blocking with horse normal serum, then with diluted monoclonal antibody for 60 min, with biotin-labelled horse anti-mouse immunoglobulin for 30 min, and finally with horseradish peroxidase-conjugated avidinbiotin complex for 45 min. The reaction was developed using diaminobenzidine (1 mg/ml, Dako DAB, chromogen tablets) and 0.02% H 2 O 2 and slides were counterstained with 1/20 diluted Giemsa for 5 min. Slides were rinsed after each incubation in PBS buffer pH 7.4. All incubations were carried out in a humid chamber at room temperature. Positive cells appeared with brownish granules. The K562 and HeLa cell lines were used as negative and positive control, respectively. 
FISH analysis
The plasmid p16
INK4a genomic gene probe, kindly provided by Dr D Demetrick, University of Calgary, Canada, was obtained by labeling DNA using Nick translation kit (Gibco-BRL, Life Technologies, Eggenstein, Germany). 9 Chromosomal in situ suppression hybridization was performed as follows: 330 ng of labeled p16
INK4a plasmid DNA was coprecipitated with 10 g of Cot1 human DNA (Boehringer, Mannheim, Germany) and 5 g of salmon sperm DNA (Sigma Chemicals, St Louis, MO, USA) and was then resuspended in 20 l hybridization buffer (50% formamide, 10% dextran sulfate, 2 × SSC, pH 7). The FISH protocol has been previously described. 10 Briefly, p16 INK4a probes were denatured at 76°C and pre-annealing with Cot1 DNA at 37°C for 3 h and cohybridized with Spectrum orange labeled probe for the ␣ satellite DNA chromosome 9 (CEP9) (Vysis, Woodcreek, IL, USA) overnight on metaphases slides. Detection of the hybridized p16
INK4a probes was performed by indirect immunofluorescence using FITC-conjugated avidin (Vector Laboratories) in combination with biotinylated goat anti-avidin (Vector Laboratories). After counterstaining with 4,6-diamidino-2-phenylindole-dihydro-chloride (DAPI) (0.2 g/ml), the slides were evaluated using a Zeiss Axioskop epifluorescence microscope (Zeiss, Oberkochen, Germany) equipped with a triple-bandpass filter. Fluorescence images were captured using the Quips Smart Capture FISH Imaging Software (Vysis). For each slide, 15 metaphases were analyzed, on average.
Statistical analysis
Statistical analyses were performed on SPSS 9.0 analysis software (SPSS, Chicago, IL, USA). The chi-square and Fisher's exact test were used for comparison between subgroups. Overall (OS) and event-free survival (EFS) between ICC-positive and -negative subgroups were analyzed using the log-rank test. Events were defined as induction death, relapse, and death in complete remission. A separate analysis of EFS and OS was also performed on ALL with standard risk karyotype defined by exclusion of t(9;22)(q34;q11), t(4;11)(q21;q23), t(1;19)(q23;p13), and hypodiploid.
Leukemia
Results
Correlation between p16
INK4a ICC and FISH analysis (2)t(2;8)(p12;q24), 2 GG del(3)(q21q27),(0-1)der(11)t(7;11)(q21;p13),(0-1)del(14)(q23) [16] ND, not done; G, germline; D, deletion. Table 2 . Median percentage of bone marrow infiltration by blast cells was 95% (43-99). Twenty-seven (43.5%) samples were ICC-positive. No difference for sex ratio, tumor mass, white blood cell count (WBC), CNS disease, FAB type, hemoglobin, karyotype, and response rate could be observed between ICC-positive and -negative cases. However, ALL with positive ICC were significantly more frequently of B lineage and older than 55 years than ALL with negative ICC.
INK4a ICC and prognosis of adult ALL
Comparison of OS and EFS between patients according to their p16
INK4a ICC status did not show statistically significant differences (P = 0.243 and P = 0.335, respectively, log rank test). However, when patients with standard risk karyotype (ie excluding t(9;22), t(4;11), t(1;19) and hypodiploid) were analyzed, patients with positive ICC showed better OS (P = 0.05) ( Figure 2 ) and EFS ( Figure 3 ) (P = 0.0313). We also analyzed OS and EFS in patients with B lineage ALL and standard risk karyotype. A trend to better OS and EFS was observed but differences were not significant (P = 0.09 and P = 0.11 respectively, log rank test) (Figure 4 ).
Sequential analysis of p16
INK4a ICC
Nineteen patients with ALL were analyzed in relapse (Table 3) . Among them, nine were also analyzed at diagnosis and two also in second relapse. Proportions of positive samples by ICC were not significantly different between diagnosis and first relapse (P = 0.164). However, ICC status changed between diagnosis and first or second relapse in four patients. One patient with positive ICC had negative ICC in first relapse, three patients with negative ICC at first analysis, had positive ICC in first or second relapse.
Discussion
p16
INK4a gene expression has been analyzed in hematological malignancies by a variety of methods, including RT-PCR, Western blot, flow cytometry, and immunocytochemistry. 1, 3, 4, 6, 11, 12 Flow cytometry is an extremely sensitive technique, but the need for prior permeabilization to study p16
INK4a can induce substantial morphological changes in leukemic blasts. Immunocytochemistry technique allows direct identification of leukemic cells leading to easier interpretation. In this study, we observed a good correlation between FISH analysis of p16
INK4a gene deletions and ICC. All samples with p16
INK4a gene homozygous deletion by FISH were ICC-negative. However, among 17 samples with hemizygous or no evidence of p16
INK4a gene deletion, six were ICC-negative, suggesting that ICC provides a more global analysis of the p16
INK4a gene in ALL. We chose a cut-off value of more than 5% of positive cells to consider samples positive for ICC. Five percent of bone marrow cells is the common limit of blast cell proportion considered as nonpathological. Moreover, it has been previously reported that p16
INK4a expression was higher in CD34
+ than CD34 − bone marrow cells from healthy donors. 13 Thus our choice of Ͼ5% for ICC lowers the prob- Table 2 Presenting features of adult with ALL studied by p16 INK4a ICC at diagnosis (n = 62) ability of counting non-clonal immature bone marrow cell as leukemic cells. All eight control bone marrow samples were negative for ICC in every cell, however, one leukemic sample with p16
INK4a gene homozygous deletion showed 5% ICCpositive cells. It can be hypothesized that p16
INK4a expression in normal bone marrow residual cells from leukemic patients could not be exactly the same as p16
INK4a expression in bone marrow cells from healthy patients. Thus a cut-off value of 5% seems necessary to avoid false positives.
Samples negative for ICC were more frequently of T lineage, in agreement with previous reports showing that a large proportion of T ALL had p16
INK4a gene homozygous deletion. 1 Moreover, in the present study, FISH analysis of eight T ALL showed five homozygous and two hemizygous deletions. Thus in T-ALL, negative ICC is mostly related to gene deletions. Many studies have also reported that patients with ALL and p16 INK4a gene deletions were more susceptible to having large bulky mass and higher white blood cell count, but other reports have not confirmed these results. [14] [15] [16] [17] [18] [19] We found by p16 INK4a ICC no difference for sex, bulky mass, INK4a ICC for OS and EFS in the whole population, differences were not significant. However, the population of patients without unfavorable karyotype differed significantly both for OS and EFS. We also analyzed OS and EFS in patients with B lineage ALL and standard risk karyotype, and a trend for better OS and EFS was observed in patients with positive ICC, but the number of patients was too small to make definitive conclusions. Several studies have investigated the impact of p16
INK4a gene deletions or absence of expression in adult or childhood ALL. Several reports did not find statistically significant differences of outcome according to p16 INK4a status. 5, 17, 19 However, recently, Stock et al 4 have shown that p16
INK4a abnormalities had prognostic value in adult ALL when combined with p53 and Rb mutations. They hypothesized that multiple tumor suppressor gene abnormalities in adult ALL masked the prognostic effect of any single gene abnormality. Heerema et al 20 have shown that chromosome 9p deletion, where the p16
INK4a gene is located, is associated with adverse risk in child with standard risk ALL. However, it has been also reported that enhanced expression of p16 INK4a gene was associated with poor prognosis in childhood ALL. 3 The high level of p16
INK4a expression group was associated with high proliferation rate and enhanced cellular survival. We also observed in our study, in some patients with unfavorable karyotype, a high proportion of leukemic cells expressing the p16
INK4a protein, but the difference was not statistically significant. It can be hypothesized that leukemic cells in a subset of ALL patients might have specific gene abnormalities leading to enhanced cell proliferation and to increased p16
INK4a expression, as p16 INK4a expression physiologically peaks in S phase of the cell cycle. In agreement with this hypothesis, we observed in three patients studied both at diag
